Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
algorithm
allergic angiitis
amaurosis fugax
ammonia
andexanet
aneurysm, intracranial
antiarrhythmic drugs
anticardiolipin antibodies
anticoagulant, complications of
anticoagulant, reversal of
anticoagulant, treatment
anticoagulant, treatment in CVD
anticoagulation effect
anti-myeloperoxidase
antiphospholipid antibodies
apixaban
arteritides
arthralgia
asthma
atrial fibrillation
battered child syndrome
bedridden
behavioral disorder
burning feet
burning paresthesia
CAT scan
CAT scan, abnormal
cerebral edema
cerebral ischemia
cerebrospinal fluid
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, multiple
cerebrovascular accident, prevention of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular disease, risk factors in
chest x-ray
chest x-ray, abnormal
child abuse
children
Churg-Strauss syndrome
ciraparantag
Clinical Pathologic Conference(C.P.C.)
coagulopathy
coma
complications
confusion
cost
coumarin
cystic fibrosis, neurologic complications with
dabigatran
disseminated intravascular coagulation(DIC)
door to needle time
drug induced neurologic disorders
edema, pedal
edoxaban
efficacy
encephalomyelitis, postinfectious
encephalopathy
eosinophilia
epidemiology of neurology
facial nerve palsy
factor Xa inhibitor
failure to thrive
false positive VDRL
fever
fibrinolytic agents
fibrinolytic agents, contraindications
fibrinolytic therapy, timing of administration
fresh frozen plasma
gastrointestinal bleeding
handwriting
head injury
head injury, defibrination following
head injury, pediatric
headache
hematuria, gross
hematuria, microscopic
hemiplegia
hemorrhagic diathesis
hemostatic therapy
heparin
hepatolenticular degeneration(Wilson's disease)
hepatomegaly
hyperbilirubinemia
hyperesthesia
idarucizumab
influenza A virus
INR values
intracerebral hemorrhage
intracerebral hemorrhage, lobar
intracerebral hemorrhage, progression of
intracerebral hemorrhage, volume
intracranial hemorrhage
intracranial pressure monitoring
laboratory values, normal
leg weakness, bilateral
lethargy
level of consciousness, decreased
liver biopsy
liver function enzymes
lupus anticoagulant
malabsorption
migraine
mononeuritis multiplex
mononeuropathy multiplex
mortality
muscle biopsy
muscle pain
nasal polyp
nausea and vomiting
nerve biopsy
nerve conduction studies
neuropathy
neuropathy, painful
neuropathy, peripheral
neuropathy, vasculitic, systemic
non-vitamin K antagonist oral anticoagulants
non-vitamin K antagonist oral anticoagulants, coagulation test
old age, neurology of
optic neuropathy
optic neuropathy, ischemic
pain
pain, foot
pain, leg
paraparesis
paresthesias
partial thromboplastin time
partial thromboplastin time, prolonged
peri-procedural
petechiae
pleurisy
pneumonia
practice guidelines
prevention of neurologic disorders
prothrombin complex concentrate
prothrombin time
prothrombin time, prolonged
protocol violations
pulmonary infiltrates
quinidine
quinine
rash
retinal infarction
review article
Reye's syndrome
Reye's syndrome, adult
risk factors
rivaroxaban
safety
seizure
serum glutamic oxaloacetic transaminase
skin, biopsy
skin, hematoma
skin, lesions in neurologic disorders
steroid therapy, CNS treatment and complications with
stool, guaiac positive
stroke protocol
subdural hematoma
thrombocytopenia
time is brain
tissue plasminogen activator, intravenous
treatment of neurologic disorder
tremor
tremor, intention
vasculitides
viral infection
viral infection, CNS
vitamin K
vitamin K deficiency
writing
Showing articles 0 to 50 of 4546 Next >>

Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage
Stroke 50:529-536, Bower, M.M.,et al, 2019

Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy
JAMA 320:1485-1486, Sholzberg, M. & Xu, Y., 2018

Intracerebral Hemorrhage Associated with Oral Anticoagulant Therapy
Stroke 37:256-262, Steiner, T.,et al, 2006

An Expedited Code Stroke Protocol Is Feasible and Safe
Stroke 37:2935-2939,2863, Sattin,J.A.,et al, 2006

Predicting Abnormal Coagulation in Ischemic Stroke: Reducing Delay in rt-PA Use
Neurol 67:1665-1667, Gottesman,R.F.,et al, 2006

Cystic Fibrosis Presenting With Intracerebral Haemorrhage
Lancet 358:1960, Merelle,M.E.,et al, 2001

Wobbly Handwriting
Lancet 351:336, Rosario,M.A.F.,et al, 1998

Coagulopathy in Pediatric Abusive Head Trauma
Pediatrics 99:371-375, Hymel,K.P.,et al, 1997

Warfarin Use Among Patients with Atrial Fibrillation
Stroke 28:2382-2389, Brass,L.M.,et al, 1997

Bleeding During Antithrombotic Therapy in Patients with Atrial Fibrillation
Stroke Prevention in Atrial Fib Invest, Arch Int Med 156:409-4161996., , 1996

Clinicopath Conf
Qunidine-Induced Thrombocytopenia, Cerebral Hemorrhage, Case 15-1995, NEJM 332:1363-137095., , 1995

Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
Ann Int Med 120:897-902, Hylek,E.M.&Singer,D.E., 1994

Risk Factors for Complications of Chronic Anticoagulation
Ann Int Med 118:511-520, Fihn,S.D.,et al, 1993

Laboratory Monitoring of Oral Anticoagulant Therapy:Are We Being Misled?
Neurol 43:468-470, Albers,G.W., 1993

Effect of Laboratory Variation in the Prothrombin-Time Ratio on the Results of Oral Anticoagulant Therapy
NEJM 329:696-702, Eckman,M.H.,et al, 1993

Anticoagulant-Related Bleeding:Clinical Epidemiology, Prediction, and Prevention
Am J Med 95:315-328, Landefeld,C.S.&Beyth,R.J., 1993

Clinicopath Conf
Churg-Strauss Syndrome, Case 18-1992, NEJM 326:1204-1212992., , 1992

Reliance on Prothrombin Time Ratios Causes Significant Errors in Anticoagulation Therapy
Arch Int Med 152:278-282, 2571992., Bussey,H.I.,et al, 1992

Clinicopath Conf
Churg-Strauss Phenomena with Mononeuritis Multiplex, Case Record 38-1990, NEJM 323:812-822990., , 1990

Neurological Disease Associated with Antiphospholipid Antibodies
Ann Neurol 25:221-227, Briley,D.P.,et al, 1989

Reye's Syndrome in Adults, Diagnostic Considerations
Arch Int Med 147:61-64, Meythaler,J.M.&Varma,R.R., 1987

Reye's Syndrome in the Adult Patient
Am J Med 67:672-678, Atkins,J.N.,et al, 1979

A 62-Year-Old Woman with Progressive Spasticity, Weakness,and Gait Instability
Neurol 104:e210290, Voloshyna-Farber, E.Y.,et al, 2025

Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025

Palliative and End-of-Life Care in Stroke:A Scientific Statement from the American Heart Association
Stroke 56;e75-e86, Creutzfeldt,C.J.,et al, 2025

Spontaneous Spinal Cord Infarction in a Young Patient: An Overview of Clinical Features and Management
Stroke 56:58-61, Chornay,C.,et al, 2025

A 68-YEar-Old Man with Progressive Numbness, Vertigo, and Cognitive Decline
Neurol 104:e213437, Regan,S.M. & Davalos,L.F., 2025

Polka Dot Intracerebral Hemorrhage in Leukemia
Stroke 56:e49-e50, Rebchuk,A.D.,et al, 2025

Clinical Presentation, Investigation Findings, and Outcomes of IgG4-Related Pachymeningitis,A Systematic Review
JAMA Neurol 82:193-199, Terrim,S.,et al, 2025

Juvenile-Onset Dopa-Responsive Dystonia-Until It Isnt
Neurol 104:e213436, Paredes,N.C.,et al, 2025

A 19-Year-Old Woman with Progressive Weakness and Numbness in Her Arms and Legs
Neurol 104:e213495, Alsabah,A-A.,et al, 2025

A 60-Year-Old Man with Weakness and Gait Dysfunction
JAMA Neurol 82:305-306, Jones,F.J.S.,et al, 2025

Functional Outcome in Patients with Carotid Artery Dissection Undergoing Thrombectomy or Standard Medical Treatment
Neurol 104:e213465, Sykora,M.,et al, 2025

A 56-Year-Old Woman with New-Onset Hoarsement and Dysphagia
Neurol 104:e213363, McAree,M. & Frontera, J.A., 2025

Calcitonin Gene-Related Peptide-Targeted Therapy in Migraine: Current Role and Future Perspectives
Lancet 405:1014-1026, Versijpt,J.,et al, 2025

Endovascular Therapy for Patients with Low NIHSS Scores and Large Vessel Occlusion in the 6- to 24-Hour Window
Neurol 104:e213442, Marto,J.P.,et al, 2025

Congenital Titinopathy:Comprehensive Characterization of the Most Severe End of the Disease Spectrum
Ann Neurol 97:611-628, Coppens,S.,et al, 2025

Alteplase for Posterior Circulation Ischemic Stropke at 4.5 to 24 Hours
NEJM 392:1288-1296, Yan,S.,et al, 2025

Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion
NEJM 392:1385-1395,1440, Goyal,lM.,et al, 2025

Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels
NEJM 392:1374-1384,1440, Psychogios,M.,et al, 2025

Long-Term Effects of Antidarsagene Autotemcel for Metachromatic Leukodystrophy
NEJM 392:1609-1620, Fumagalli,F.,et al, 2025

Low Hemoglobin Causes Intracerebral Hemorrhage Outcomes
Stroke 56:1234-1242, Cottarelli,A., et al, 2025

Clinicopathologic Conference, Cryptococcus Neoformans and Cushings Syndrome
NEJM 392:1847-1856, Case 13-2025, 2025

Progress Toward Mitigating Disability Progression in Multiple Sclerosis
NEJM 392:1966-1968, Calabresi,P.A., 2025

A 57-Year-Old Man With Chronic Gait Unsteadiness and Diminished Lower Extremity Sensation
Neurol 104:e213713, Rawat,R.,et al, 2025

A 59-Year-Old Man with Progressive Dysarthria and Gait Instability
Neurol 104:e213729, Shen,D.,et al, 2025

Distinguishing Transient Cerebral Ischemia From Other Brief Neurologic Events
Neurol 102:e208024, Warach,S. & Schellinger, P.D., 2024

A Young Woman With Hypertonia, Severe Scoliosis, and Encephalopathy
JAMA Neurol 81:83-84, Hua,L.,et al, 2024

Neurovascular Complications of Iatrogenic Fusarium solani Meningitis
NEJM 390:522-529, Strong, N.,et al, 2024



Showing articles 0 to 50 of 4546 Next >>